Jianqing Lin

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo et al. · Journal of Clinical Oncology · 2014 · 281 citations · Full text

Medicine, Oncology, Urology +13

The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.

Jianqing Lin, Rosalyn M. Adam, Eric Santiestevan et al. · PubMed · 1999 · 242 citations

Life Sciences, Oncology, Pharmacology +17

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

Jianqing Lin, Michael C. Haffner, Yonggang Zhang et al. · The Prostate · 2010 · 193 citations · Full text

Medicine, Oncology, Pharmacology +13

Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor

Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. · PLoS ONE · 2010 · 152 citations · Full text

Life Sciences, Genetics, Oncology +14